Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020.
Sumner KM, Sahni LC, Boom JA, Halasa NB, Stewart LS, Englund JA, Klein EJ, Staat MA, Schlaudecker EP, Selvarangan R, Harrison CJ, Weinberg GA, Szilagyi PG, Singer MN, Azimi PH, Clopper BR, Moline HL, Noble EK, Williams JV, Michaels MG, Olson SM; New Vaccine Surveillance Network Collaborators. Sumner KM, et al. Among authors: englund ja. JAMA Netw Open. 2024 Dec 2;7(12):e2452512. doi: 10.1001/jamanetworkopen.2024.52512. JAMA Netw Open. 2024. PMID: 39729317
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study.
Antoon JW, Amarin JZ, Hamdan O, Stopczynski T, Stewart LS, Michaels MG, Williams JV, Klein EJ, Englund JA, Weinberg GA, Szilagyi PG, Schuster JE, Selvarangan R, Harrison CJ, Boom JA, Sahni LC, Muñoz FM, Staat MA, Schlaudecker EP, Chappell JD, Clopper BR, Moline HL, Campbell AP, Spieker AJ, Olson SM, Halasa NB. Antoon JW, et al. Among authors: englund ja. Clin Infect Dis. 2024 Dec 17:ciae573. doi: 10.1093/cid/ciae573. Online ahead of print. Clin Infect Dis. 2024. PMID: 39688383
Protection from COVID-19 vaccination and prior SARS-CoV-2 infection among children aged 6 months - 4 years, United States, September 2022-April 2023.
Feldstein LR, Ruffin J, Wiegand R, Grant L, Babu TM, Briggs-Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Kuntz J, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Naleway AL, Newes-Adeyi G, Odame-Bamfo L, Olsho LE, Phillips AL, Rai RP, Saydah S, Smith N, Tyner H, Vaughan M, Weil AA, Yoon SK, Britton A, Gaglani M. Feldstein LR, et al. Among authors: englund ja. J Pediatric Infect Dis Soc. 2024 Dec 5:piae121. doi: 10.1093/jpids/piae121. Online ahead of print. J Pediatric Infect Dis Soc. 2024. PMID: 39656907
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
Moline HL, Toepfer AP, Tannis A, Weinberg GA, Staat MA, Halasa NB, Boom JA, Klein EJ, Williams JV, Schuster JE, Goldstein L, McKeever ER, Kalman C, Paden C, Atherton L, Aggarwal M, Roychoudhury P, Piedra PA, Sahni LC, Stewart LS, Selvarangan R, Michaels MG, Schlaudecker EP, Szilagyi PG, Englund JA, Clopper BR, Thornburg NJ, Derado G, McMorrow ML, Dawood FS; New Vaccine Surveillance Network Collaborators. Moline HL, et al. Among authors: englund ja. JAMA Pediatr. 2024 Dec 9:e245572. doi: 10.1001/jamapediatrics.2024.5572. Online ahead of print. JAMA Pediatr. 2024. PMID: 39652359
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024.
Frutos AM, Ahmad HM, Ujamaa D, O'Halloran AC, Englund JA, Klein EJ, Zerr DM, Crossland M, Staten H, Boom JA, Sahni LC, Halasa NB, Stewart LS, Hamdan O, Stopczynski T, Schaffner W, Talbot HK, Michaels MG, Williams JV, Sutton M, Hendrick MA, Staat MA, Schlaudecker EP, Tesini BL, Felsen CB, Weinberg GA, Szilagyi PG, Anderson BJ, Rowlands JV, Khalifa M, Martinez M, Selvarangan R, Schuster JE, Lynfield R, McMahon M, Kim S, Nunez VT, Ryan PA, Monroe ML, Wang YF, Openo KP, Meek J, Yousey-Hindes K, Alden NB, Armistead I, Rao S, Chai SJ, Kirley PD, Toepfer AP, Dawood FS, Moline HL, Uyeki TM, Ellington S, Garg S, Bozio CH, Olson SM. Frutos AM, et al. Among authors: englund ja. MMWR Morb Mortal Wkly Rep. 2024 Nov 14;73(45):1022-1029. doi: 10.15585/mmwr.mm7345a2. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39541236 Free PMC article.
On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network.
Hofstetter AM, Klein EJ, Strelitz B, Selvarangan R, Schuster JE, Boom JA, Sahni LC, Halasa NB, Stewart LS, Staat MA, Rohlfs C, Szilagyi PG, Weinberg GA, Williams JV, Michaels MG, Moline H, Mirza SA, Harrison CJ, Englund JA. Hofstetter AM, et al. Among authors: englund ja. Vaccine. 2024 Dec 2;42(26):126455. doi: 10.1016/j.vaccine.2024.126455. Epub 2024 Oct 30. Vaccine. 2024. PMID: 39481240
Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019-2021.
Cox SN, Casto AM, Franko NM, Chow EJ, Han PD, Gamboa L, Pfau B, Xie H, Kong K, Sereewit J, Rolfes MA, Mosites E, Uyeki TM, Greninger AL, Carone M, Shim MM, Bedford T, Shendure J, Boeckh M, Englund JA, Starita LM, Roychoudhury P, Chu HY. Cox SN, et al. Among authors: englund ja. Emerg Infect Dis. 2024 Nov;30(11):2250-2260. doi: 10.3201/eid3011.240687. Emerg Infect Dis. 2024. PMID: 39447143 Free PMC article.
Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective Study.
Grioni HM, Sullivan E, Strelitz B, Lacombe K, Klein EJ, Boom JA, Sahni LC, Michaels MG, Williams JV, Halasa NB, Stewart LS, Staat MA, Schlaudecker EP, Selvarangan R, Harrison CJ, Schuster JE, Weinberg GA, Szilagyi PG, Singer MN, Azimi PH, Clopper BR, Moline HL, Campbell AP, Olson SM, Englund JA. Grioni HM, et al. Among authors: englund ja. J Pediatric Infect Dis Soc. 2024 Oct 10:piae108. doi: 10.1093/jpids/piae108. Online ahead of print. J Pediatric Infect Dis Soc. 2024. PMID: 39387655
RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing.
Wilkins D, Wählby Hamrén U, Chang Y, Clegg LE, Domachowske J, Englund JA, Muller WJ, Leach A, Kelly EJ, Villafana T. Wilkins D, et al. Among authors: englund ja. Pediatrics. 2024 Nov 1;154(5):e2024067174. doi: 10.1542/peds.2024-067174. Pediatrics. 2024. PMID: 39350745 Clinical Trial.
453 results